Health and Fitness Health and Fitness
Mon, July 9, 2012
[ Mon, Jul 09th 2012 ] - Market Wire
SpectraScience Reports Estimated Second Quarter Revenue of $310,000
[ Mon, Jul 09th 2012 ] - Market Wire
BIOLASE Files Amendment to 2011 Form 10-K to Upda .. Associated With Henry Schein Settlement Agreement
[ Mon, Jul 09th 2012 ] - Market Wire
Luminex Corporation Announces Agreement to Acquire GenturaDx
[ Mon, Jul 09th 2012 ] - Market Wire
Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
[ Mon, Jul 09th 2012 ] - Market Wire
Novavax and XOMA Showing Investors Strong Gains i .. ntinues to Thrive Five Star Equities Provides Sto
[ Mon, Jul 09th 2012 ] - Market Wire
MethylGene to Present at the Seventh Annual JMP Securities Healthcare Conference
[ Mon, Jul 09th 2012 ] - Market Wire
Sitoa Global Announces Strategic Partnership With CITIC
[ Mon, Jul 09th 2012 ] - Market Wire
Ceapro Announces Re-Election of Board, Adoption o .. Option Plan and Appointment of President and CEO
[ Mon, Jul 09th 2012 ] - Market Wire
MELA Sciences Announces Positive Results of Impact of MelaFind in German Clinical Study
[ Mon, Jul 09th 2012 ] - Market Wire
InterMune To Present At JMP Securities Healthcare Conference
[ Mon, Jul 09th 2012 ] - Market Wire
Korea Intellectual Property Tribunal Holds Given Imaging Patents Valid
[ Mon, Jul 09th 2012 ] - Market Wire
EnteroMedics to Present at Seventh Annual JMP Securities Healthcare Conference
[ Mon, Jul 09th 2012 ] - Market Wire
Delcath Announced Changes To Board Of Directors
[ Mon, Jul 09th 2012 ] - Market Wire
OncoSec Initiates Phase II Clinical Program in Cutaneous T-Cell Lymphoma and Doses First Patient
[ Mon, Jul 09th 2012 ] - Market Wire
BioLife Solutions Completes First $1 Million Revenue Quarter
[ Mon, Jul 09th 2012 ] - Market Wire
Cord Blood America Announces Agreement To Restructure Debt
[ Mon, Jul 09th 2012 ] - Market Wire
Highlights of significant results on Orally admin .. Macular Edema (DME), including results for visua
Fri, July 6, 2012
[ Fri, Jul 06th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. xcess of $100,000 Investing in LHC Group, Inc. To
[ Fri, Jul 06th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. 0,000 Investing in LHC Group, Inc. To Contact the
[ Fri, Jul 06th 2012 ] - Market Wire
Ki Yong Choi Reminds Cryo-Cell Stockholders to VOTE the GOLD Proxy Card for Director Nominees
[ Fri, Jul 06th 2012 ] - Market Wire
Skystar Announces Crowe Horwath (HK) CPA Limited .. New Independent Registered Public Accounting Firm
[ Fri, Jul 06th 2012 ] - Market Wire
InternetArray Forms New Business Initiative
[ Fri, Jul 06th 2012 ] - Market Wire
AVI BioPharma to Present Company Overview at the .. venth Annual JMP Securities Healthcare Conference
[ Fri, Jul 06th 2012 ] - Market Wire
Cempra, Inc. to Present at the Global Technology .. -Infectives Partnering and Deal-Making Conference
[ Fri, Jul 06th 2012 ] - Market Wire
Depomed To Present At JMP Securities 7th Annual Healthcare Conference
[ Fri, Jul 06th 2012 ] - Market Wire
Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
[ Fri, Jul 06th 2012 ] - Market Wire
Stock Alerts For Amgen, Polo Ralph Lauren, PulteG .. l, and China Unicom Released By InvestorsObserver
[ Fri, Jul 06th 2012 ] - Market Wire
SpectraScience to Present at the OneMed Forum on July 12th
[ Fri, Jul 06th 2012 ] - Market Wire
Ki Yong Choi Demands Release Of Cryo-Cell's Finan .. er Ended May 31, 2012 Prior To The Annual Meeting
[ Fri, Jul 06th 2012 ] - Market Wire
Avanir Pharmaceuticals To Present At The Seventh Annual JMP Securities Healthcare Conference

Avanir Pharmaceuticals To Present At The Seventh Annual JMP Securities Healthcare Conference


Published on 2012-07-06 05:36:30 - Market Wire
  Print publication without navigation


Avanir Pharmaceuticals To Present At The Seventh Annual JMP Securities Healthcare... -- ALISO VIEJO, Calif., July 6, 2012 /PRNewswire/ --

Avanir Pharmaceuticals To Present At The Seventh Annual JMP Securities Healthcare Conference

[ ]

ALISO VIEJO, Calif., July 6, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: [ AVNR ]) today announced that company management will present an overview of the company at the Seventh Annual JMP Securities Healthcare Conference.

    • Location: The Peninsula Hotel, New York, NY
    • Presentation date: Thursday July 12, 2012
    • Presentation time: 1:00 p.m. ET

A live webcast and 30-day archive of this presentation will be available at [ http://ir.avanir.com ].

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact Ian Clements, PhD [ ir@avanir.com ] +1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.



[ Back to top ]

RELATED LINKS
[ www.avanir.com ]

Contributing Sources